Long noncoding RNA CYTOR in cancer: A TCGA data review
Conclusion Overall, this study indicates that CYTOR may serve as a prognostic biomarker for cancer patients during the follow-up.
Source: Clinica Chimica Acta - Category: Laboratory Medicine Source Type: research
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Carcinoma | Colon Cancer | Colorectal Cancer | Databases & Libraries | Esophagus Cancer | Gastric (Stomach) Cancer | Gastroenterology | Hepatocellular Carcinoma | Kidney Cancer | Laboratory Medicine | Liver Cancer | Renal Cell Carcinoma | Skin Cancer | Squamous Cell Carcinoma | Study